These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 28514821)
21. In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop. Dassau E; Palerm CC; Zisser H; Buckingham BA; Jovanovic L; Doyle FJ Diabetes Technol Ther; 2009 Mar; 11(3):187-94. PubMed ID: 19191486 [TBL] [Abstract][Full Text] [Related]
22. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes. Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869 [TBL] [Abstract][Full Text] [Related]
23. Insulin pumps: from inception to the present and toward the future. Alsaleh FM; Smith FJ; Keady S; Taylor KM J Clin Pharm Ther; 2010 Apr; 35(2):127-38. PubMed ID: 20456732 [TBL] [Abstract][Full Text] [Related]
24. Use of sensor-augmented insulin pump in patient with diabetes and cystic fibrosis: evidence for improvement in metabolic control. Klupa T; Małecki M; Katra B; Cyganek K; Skupień J; Kostyk E; Pietrzyk J; Sieradzki J Diabetes Technol Ther; 2008 Feb; 10(1):46-9. PubMed ID: 18275362 [TBL] [Abstract][Full Text] [Related]
25. Holistic Impact of Closed-Loop Technology on People With Type 1 Diabetes. Young AJ; Thabit H; Heller SR; Evans ML; Amiel SA; Hovorka R; Barnard KD J Diabetes Sci Technol; 2015 Jul; 9(4):932-3. PubMed ID: 25852073 [No Abstract] [Full Text] [Related]
26. Multinight "bedside" closed-loop control for patients with type 1 diabetes. Brown SA; Kovatchev BP; Breton MD; Anderson SM; Keith-Hynes P; Patek SD; Jiang B; Ben Brahim N; Vereshchetin P; Bruttomesso D; Avogaro A; Del Favero S; Boscari F; Galasso S; Visentin R; Monaro M; Cobelli C Diabetes Technol Ther; 2015 Mar; 17(3):203-9. PubMed ID: 25594434 [TBL] [Abstract][Full Text] [Related]
27. An Improved PID Algorithm Based on Insulin-on-Board Estimate for Blood Glucose Control with Type 1 Diabetes. Hu R; Li C Comput Math Methods Med; 2015; 2015():281589. PubMed ID: 26550021 [TBL] [Abstract][Full Text] [Related]
28. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L; Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775 [TBL] [Abstract][Full Text] [Related]
30. [The artificial pancreas, a dream on the point of becoming reality]. Renard É; Place J; Benbrahim N; Diouri O; Farret A Rev Infirm; 2017 Apr; 66(230):35-37. PubMed ID: 28366258 [TBL] [Abstract][Full Text] [Related]
31. Decision Support Systems and Closed Loop. Nimri R; Ochs AR; Pinsker JE; Phillip M; Dassau E Diabetes Technol Ther; 2019 Feb; 21(S1):S42-S56. PubMed ID: 30785322 [No Abstract] [Full Text] [Related]
32. NICE recommends hybrid closed loop systems for poorly controlled type 1 diabetes. Mahase E BMJ; 2023 Nov; 383():2619. PubMed ID: 37940182 [No Abstract] [Full Text] [Related]
33. Successful Use of an Advanced Hybrid Closed-loop System in a Patient With Type 3c Pancreatogenic Diabetes Secondary to Nesidioblastosis. Amuedo S; Bellido V; Mangas Cruz MÁ; Gros Herguido N; López Gallardo G; Pérez Morales A; Soto Moreno A Can J Diabetes; 2023 Mar; 47(2):193-196. PubMed ID: 36207270 [No Abstract] [Full Text] [Related]
34. Opportunities and challenges in closed-loop systems in type 1 diabetes. Wilson LM; Jacobs PG; Riddell MC; Zaharieva DP; Castle JR Lancet Diabetes Endocrinol; 2022 Jan; 10(1):6-8. PubMed ID: 34762835 [No Abstract] [Full Text] [Related]
35. Relevance of Bolus Calculators in Current Hybrid Closed Loop Systems. Forlenza GP Diabetes Technol Ther; 2017 Jul; 19(7):400-401. PubMed ID: 28686041 [No Abstract] [Full Text] [Related]
36. Decision Support Systems and Closed-Loop. Nimri R; Kovatchev B; Phillip M Diabetes Technol Ther; 2021 Jun; 23(S2):S69-S84. PubMed ID: 34061631 [No Abstract] [Full Text] [Related]
37. Decision Support Systems and Closed-Loop. Nimri R; Phillip M; Kovatchev B Diabetes Technol Ther; 2022 Mar; 24(S1):S58-S75. PubMed ID: 35475696 [No Abstract] [Full Text] [Related]
38. User Engagement With the CamAPS FX Hybrid Closed-Loop App According to Age and User Characteristics. Chen NS; Boughton CK; Hartnell S; Fuchs J; Allen JM; Willinska ME; Thankamony A; de Beaufort C; Campbell FM; Fröhlich-Reiterer E; Hofer SE; Kapellen TM; Rami-Merhar B; Ghatak A; Randell TL; Besser REJ; Elleri D; Trevelyan N; Denvir L; Davis N; Gurnell E; Lindsay R; Morris D; Scott EM; Bally L; Thabit H; Leelarathna L; Evans ML; Murphy HR; Mader JK; Hovorka R; Diabetes Care; 2021 Jul; 44(7):e148-e150. PubMed ID: 34021021 [No Abstract] [Full Text] [Related]
39. The importance of prandial insulin bolus timing with hybrid closed-loop systems. Boughton CK; Hartnell S; Allen JM; Hovorka R Diabet Med; 2019 Dec; 36(12):1716-1717. PubMed ID: 31441093 [No Abstract] [Full Text] [Related]
40. Inside the skin of a patient with diabetes: fostering cognitive empathy through insulin pump simulation. Ryan PM Can Med Educ J; 2021 Feb; 12(1):e92-e94. PubMed ID: 33680237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]